You are here

AR-101

Top 5 New Drug Launches of 2019 -- and the Biotech Stocks That Could Win Big

Motley Fool

Sun, 05/19/19 - 04:05 pm

Aimmune Therapeutics

Aimmune's peanut allergy immunotherapy clears European PhIII with flying colors, paving way for first US, EU therapeutic approval

Endpoints

Mon, 03/25/19 - 12:03 pm

DBV Rejoins Peanut Allergy Treatment Race, But Aimmune Takes the Lead

Xconomy

Thu, 02/14/19 - 12:08 am

DBV Technologies